Drugs - Real World Outcomes targets research involving the use of real-world data to evaluate health outcomes and inform healthcare decision-making, with a particular focus on healthcare-related 'big data'. Drugs - Real World Outcomes has a broad scope, encompassing studies investigating drug utilisation, patterns of prescribing, pharmacovigilance, treatment guideline adherence, benefit-risk assessments, comparative effectiveness and economic analyses.

Drugs - Real World Outcomes offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review (single-blind) is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

Manuscripts submitted to the journal for publication will be subject to an article processing charge (APC) upon acceptance. Please click on the ‘Fees and funding’ link for details of the current APC and open access funding and support services. Adis Open Access enables you to make your journal article freely available to anyone, in exchange for payment of the APC. This option allows you, the author, to retain the copyright of the article according to the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC) License, which does not permit commercial re-use of the article.

Journal information

Editor-in-Chief
  • Dene Peters
Associate Editor
  • Sophie Stevenson
Publishing model
Open Access. How to publish with us

Journal metrics

50 days
Submission to first decision (Median)
130,441 (2021)
Downloads

Latest articles

Journal updates

  • Digital Features

    Drugs - Real World Outcomes is able to host a range of digital features, with a number of options available to authors.

    Digital Features
View all updates

About this journal

Electronic ISSN
2198-9788
Abstracted and indexed in
  1. BIOSIS
  2. Baidu
  3. Biological Abstracts
  4. CLOCKSS
  5. CNKI
  6. CNPIEC
  7. DOAJ
  8. Dimensions
  9. EBSCO Discovery Service
  10. EMBASE
  11. EMCare
  12. Emerging Sources Citation Index
  13. Gale
  14. Google Scholar
  15. Naver
  16. Norwegian Register for Scientific Journals and Series
  17. OCLC WorldCat Discovery Service
  18. Portico
  19. ProQuest ABI/INFORM
  20. ProQuest-ExLibris Primo
  21. ProQuest-ExLibris Summon
  22. PubMedCentral
  23. SCImago
  24. SCOPUS
  25. Semantic Scholar
  26. TD Net Discovery Service
  27. UGC-CARE List (India)
  28. Wanfang
Copyright information

Rights and permissions

Springer policies

© Springer Nature Switzerland AG